American Rebel Q2 2026: Going Concern Warning, Nasdaq Delisting, and Deepening Losses
AREBW sits 50% above its 52-week low of $0.001 on elevated volume (1.8× avg).
Summary
American Rebel's Q2 2026 10-Q includes a going concern warning, confirms Nasdaq delisting, and reports a $12.8M net loss with a rapidly deteriorating balance sheet.
Key Events · Earnings and Guidance · AREBW
-
Going Concern Warning
Management states there is substantial doubt about the company's ability to continue as a going concern, citing recurring losses, working capital deficit, and reliance on dilutive financing.
-
Nasdaq Delisting Finalized
Trading on Nasdaq was suspended May 13, 2026; the stock now trades on OTC Pink/OTCID, severely limiting liquidity and institutional access.
-
Deepening Losses
Net loss of $12.8M for H1 2026 on revenue of $4.0M, with gross margin negative at -14%. Accumulated deficit reached $112.4M.
-
Precarious Balance Sheet
Unrestricted cash of only $96K vs. $23.0M in current liabilities. Working capital deficit of $19.4M. The company is surviving on toxic convertible debt.
Analysis · AREBW · Manufacturing
The 10-Q from American Rebel paints a picture of severe distress. An explicit going concern warning from the auditor flags substantial doubt about the company's ability to continue. Nasdaq delisting took effect in May, pushing the stock to the OTC Pink market. The balance sheet is alarming: a $19.4M working capital deficit and $112.4M accumulated deficit, against just $96K in unrestricted cash. To stay afloat, the company leans on highly dilutive convertible debt with punitive terms, converting millions of dollars into shares at deep discounts. Revenue dropped 26% year-over-year while operating losses widened, and management acknowledges material weaknesses in internal controls. This is not a routine quarterly filing — it's a distress signal.
At the time of this filing, AREBW was trading at $0.00 on OTC in the Manufacturing sector, with a market capitalization of approximately $3.7M. The 52-week trading range was $0.00 to $0.05. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.